US3009864A
(en)
|
1958-09-18 |
1961-11-21 |
Union Carbide Corp |
Process control
|
US3228838A
(en)
|
1959-04-23 |
1966-01-11 |
Union Carbide Corp |
Preservation of biological substances
|
US3009861A
(en)
|
1961-01-13 |
1961-11-21 |
Alderton Gordon |
Isolation of bacterial spores
|
US3608030A
(en)
|
1969-05-21 |
1971-09-21 |
Howard Tint |
Method of preparing a tablet dosage-form for the immunization of the intestinal tract with live virus preparations
|
US4077227A
(en)
|
1976-11-12 |
1978-03-07 |
Regents Of The University Of Minnesota |
Method of freezing liquid material in which agglomeration is inhibited
|
US4205132A
(en)
|
1978-07-17 |
1980-05-27 |
Microlife Technics, Inc. |
Lyophilization of bacteria
|
FI59925C
(fi)
|
1980-01-11 |
1981-11-10 |
Esko Viljo Nurmi |
Foerfarande foer framstaellning av ett bakteriepreparat anvaendbart foer foerhindrande av salmonellainfektion hos fjaederfae
|
US4655047A
(en)
|
1985-03-25 |
1987-04-07 |
I.Q.F. Inc. |
Process for freezing or chilling
|
US4839281A
(en)
|
1985-04-17 |
1989-06-13 |
New England Medical Center Hospitals, Inc. |
Lactobacillus strains and methods of selection
|
DE3887353T2
(de)
|
1987-10-12 |
1994-05-05 |
Exomed Australia Pty Ltd |
Behandlungsverfahren für magen-darm-krankheiten.
|
US5045446A
(en)
|
1988-08-26 |
1991-09-03 |
Cryopharm Corporation |
Lyophilization of cells
|
US5443826A
(en)
|
1988-08-02 |
1995-08-22 |
Borody; Thomas J. |
Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli
|
WO1990001335A1
(en)
|
1988-08-02 |
1990-02-22 |
Borody Thomas J |
Treatment of gastro-intestinal disorders
|
GB2233343B
(en)
|
1989-06-30 |
1993-07-07 |
Farmos Oy |
A bacterial preparation for use in poultry
|
JP2961182B2
(ja)
|
1990-03-09 |
1999-10-12 |
ミヤリサン株式会社 |
クロストリジウム・ディフィシル下痢症および偽膜性大腸炎の予防ならびに治療用医薬組成物
|
JP2961184B2
(ja)
|
1990-05-07 |
1999-10-12 |
ミヤリサン株式会社 |
クロストリジウム・ディフィシル下痢症および偽膜性大腸炎の予防ならびに治療用医薬組成物
|
US5436002A
(en)
|
1991-01-29 |
1995-07-25 |
Mycogen Corporation |
Bacillus thuringiensisisolate PS201T6 toxin
|
RU2035186C1
(ru)
|
1992-07-09 |
1995-05-20 |
Семен Рафаилович Резник |
Профилактический биопрепарат споролакт
|
KR950703640A
(ko)
|
1992-10-09 |
1995-09-20 |
가일 케이,나우톤. |
간 보존 세포(liver reserve cells)
|
US5599795A
(en)
|
1994-08-19 |
1997-02-04 |
Mccann; Michael |
Method for treatment of idiopathic inflammatory bowel disease (IIBD)
|
WO1997008598A1
(de)
|
1995-08-25 |
1997-03-06 |
Gff Technopark |
Verfahren zur simultanen, digitalen phasenempfindlichen detektion von zeitaufgelösten, quasi-gleichzeitig erfassten datenarrays eines periodisch stimulierten systems
|
AU7362096A
(en)
|
1995-09-15 |
1997-04-01 |
Dale N. Gerding M.D. |
Methods and compositions for prevention and treatment of clostridium difficile-associated diseases
|
AUPO430496A0
(en)
|
1996-12-19 |
1997-01-23 |
Arnott's Biscuits Limited |
Prebiotics and probiotics
|
US5965128A
(en)
|
1997-08-13 |
1999-10-12 |
University Of Georgia Research Foundation Inc. |
Control of enterohemorrhagic E. coli 0157:H7 in cattle by probiotic bacteria and specific strains of E. coli
|
US5951977A
(en)
|
1997-10-14 |
1999-09-14 |
The United States Of America, As Represented By The Secretary Of Agriculture |
Competitive exclusion culture for swine
|
US6461607B1
(en)
|
1998-08-24 |
2002-10-08 |
Ganeden Biotech, Inc. |
Probiotic, lactic acid-producing bacteria and uses thereof
|
US6589771B1
(en)
|
1999-10-28 |
2003-07-08 |
Immunom Technologies, Inc. |
Methods for arousing dormant bacteria
|
US20030118547A1
(en)
|
2000-01-27 |
2003-06-26 |
Vandenberg Grant William |
Composition for intestinal delivery
|
WO2001058465A2
(en)
|
2000-02-10 |
2001-08-16 |
Gregor Reid |
Probiotic therapy for newborns
|
US20020013270A1
(en)
|
2000-06-05 |
2002-01-31 |
Bolte Ellen R. |
Method for treating a mental disorder
|
US20040170617A1
(en)
|
2000-06-05 |
2004-09-02 |
Finegold Sydney M. |
Method of treating diseases associated with abnormal gastrointestinal flora
|
AUPQ899700A0
(en)
|
2000-07-25 |
2000-08-17 |
Borody, Thomas Julius |
Probiotic recolonisation therapy
|
BR0116178A
(pt)
|
2000-11-30 |
2003-10-14 |
Bio Balance Corp |
Cepa bacterial, composição probiótica compreendendo uma cepa bacterial, formulação compreendendo pelo menos uma fração volátil de um extrato de planta, aditivo alimentar, processo de preparação de uma fração volátil de uma planta, processo de preparação de uma formulação terapêutica, processo de crescimento de uma cepa bacterial, processo de manufatura de uma composição probiótica, processo de preparo de uma composição probiótica, processo de preparo de uma composição incluindo microorganismos viáveis, dispensador de microorganismo, método de bio controle de um organismo, método para eliminar uma poluição de óleo, método de recuperação de fumaças orgnicas, produto alimentar e método de preparo inicial para um processo de fermantação
|
CA2445205A1
(en)
|
2001-05-04 |
2003-03-27 |
University Of Florida Research Foundation, Inc. |
Cloning and sequencing of pyruvate decarboxylase (pdc) genes from bacteria and uses therefor
|
ITMI20011632A1
(it)
|
2001-07-27 |
2003-01-27 |
Sanofi Synthelabo |
Composizione solida contenente spore di batteri non patogeni del genere bacillus
|
GB0130789D0
(en)
|
2001-12-21 |
2002-02-06 |
King S College London |
Application of spores
|
US8383342B2
(en)
|
2002-04-24 |
2013-02-26 |
The University Of North Carolina At Greensboro |
Compositions, products, methods and systems to monitor water and other ecosystems
|
GB0212975D0
(en)
|
2002-06-06 |
2002-07-17 |
Mars Uk Ltd |
Mammalian animal composition
|
AU2002951692A0
(en)
|
2002-09-23 |
2002-10-17 |
Vital Biotech (Hong Kong) Limited |
Improvements in or relating to vaccines
|
US20050180962A1
(en)
|
2003-01-30 |
2005-08-18 |
Eyal Raz |
Inactivated probiotic bacteria and methods of use thereof
|
WO2004101770A1
(en)
|
2003-03-13 |
2004-11-25 |
Universite De Moncton (Bureau De Soutien A L'innovation) |
Antioxidant producing bacterium and uses thereof
|
CN100409897C
(zh)
|
2003-04-23 |
2008-08-13 |
梅达雷克斯公司 |
1型干扰素拮抗剂在制备治疗患有炎症性肠病的患者的药物中的用途
|
US20060046246A1
(en)
|
2003-04-24 |
2006-03-02 |
Qiandong Zeng |
Genus, group, species and/or strain specific 16S rDNA sequences
|
WO2004104175A2
(en)
|
2003-05-14 |
2004-12-02 |
University Of Georgia Research Foundation, Inc. |
Probiotic bacteria and methods
|
KR20060073937A
(ko)
|
2003-08-18 |
2006-06-29 |
더 바이오 밸런스 코포레이션 |
안정한 액상 촉생제 조성물, 그의 제조 및 응용
|
US7731976B2
(en)
|
2003-08-29 |
2010-06-08 |
Cobb And Company, Llp |
Treatment of irritable bowel syndrome using probiotic composition
|
US20050048515A1
(en)
|
2003-08-29 |
2005-03-03 |
Garner Bryan E. |
Methods for detecting and quantifying specific probiotic microorganisms in animal feed
|
US20050239706A1
(en)
|
2003-10-31 |
2005-10-27 |
Washington University In St. Louis |
Modulation of fiaf and the gastrointestinal microbiota as a means to control energy storage in a subject
|
US20050158294A1
(en)
|
2003-12-19 |
2005-07-21 |
The Procter & Gamble Company |
Canine probiotic Bifidobacteria pseudolongum
|
AU2005211140B2
(en)
|
2004-02-03 |
2009-12-17 |
Elanco Canada Limited |
Use of live bacteria for growth promotion in animals
|
US7632520B2
(en)
|
2004-02-16 |
2009-12-15 |
Sanjeev Khandelwal |
Synergistic antibacterial formulation and to a method of making the same
|
US7854927B2
(en)
|
2004-05-11 |
2010-12-21 |
Ganeden Biotech, Inc. |
Methods and compositions for the dietary management of autoimmune disorders
|
AU2005302390A1
(en)
|
2004-11-01 |
2006-05-11 |
Strategic Diagnostics, Inc. |
Bacteriophages as selective agents
|
US20090197249A1
(en)
|
2004-11-01 |
2009-08-06 |
George Mason University |
Compositions and methods for diagnosing colon disorders
|
US20060188523A1
(en)
|
2005-01-10 |
2006-08-24 |
Zhiheng Pei |
Methods for diagnosing and treating chronic tonsillitis
|
US7993667B2
(en)
|
2005-03-25 |
2011-08-09 |
Kimberly-Clark Worldwide, Inc. |
Methods of manufacturing a medicated tampon assembly
|
PL1885383T3
(pl)
|
2005-05-31 |
2017-06-30 |
Iams Europe B.V. |
Kocie probiotyczne bifidobakterie
|
US7452872B2
(en)
|
2005-08-24 |
2008-11-18 |
Salix Pharmaceuticals, Inc. |
Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
|
CA2622951A1
(en)
|
2005-09-28 |
2007-04-05 |
Nordisk Rebalance A/S |
Treatment of ibd and ibs using both probiotic bacteria and fermented cereal as treatment effectors
|
US8968721B2
(en)
|
2005-12-28 |
2015-03-03 |
Advanced Bionutrition Corporation |
Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
|
JP2009537138A
(ja)
|
2006-05-18 |
2009-10-29 |
バイオバランス エルエルシー |
細菌株、この細菌株を含む組成物およびそのプロバイオティック使用
|
JP5019563B2
(ja)
|
2006-06-16 |
2012-09-05 |
旭化成ケミカルズ株式会社 |
腸内細菌賦活剤
|
CN101472639A
(zh)
|
2006-06-20 |
2009-07-01 |
皇家飞利浦电子股份有限公司 |
用于治疗胃肠疾病的电子胶囊
|
TW200819540A
(en)
|
2006-07-11 |
2008-05-01 |
Genelux Corp |
Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders
|
EE05459B1
(et)
|
2006-12-08 |
2011-08-15 |
Tartu �likool |
Sporogeense Bacillus smithii tvi TBMI12 MSCL P737 ja selle endospooride kasutamine probiootikumina, toidulisandina ning probiootiline kompositsioon
|
US20100172874A1
(en)
|
2006-12-18 |
2010-07-08 |
The Washington University |
Gut microbiome as a biomarker and therapeutic target for treating obesity or an obesity related disorder
|
DE102006062250A1
(de)
|
2006-12-22 |
2008-06-26 |
Roland Saur-Brosch |
Verwendung einer Zusammensetzung aus Mineralstoffen und/oder Vitaminen und gegebenenfalls acetogenen und/oder butyrogenen Bakterien zur oralen oder rektalen Verabreichung für die Behandlung und Vorbeugung von abdominalen Beschwerden
|
WO2008083157A2
(en)
|
2006-12-29 |
2008-07-10 |
Washington University In St. Louis |
Altering pgc-1alapha, ampk, fiaf, or the gastrointestinal microbiota as a means to modulate body fat and/or weight loss in a subject
|
US8518873B2
(en)
|
2007-09-12 |
2013-08-27 |
The Medicines Company |
Method of inhibiting clostridium difficile by administration of oritavancin
|
US8236508B2
(en)
|
2008-01-29 |
2012-08-07 |
Drexel University |
Detecting and measuring live pathogens utilizing a mass detection device
|
US8021654B2
(en)
|
2008-03-14 |
2011-09-20 |
Danisco A/S |
Methods of treating pigs with Bacillus strains
|
KR20100134080A
(ko)
|
2008-04-01 |
2010-12-22 |
메타메트릭스 클리니칼 레보러토리 |
위장의 미생물상을 모니터링하기 위한 공정과 방법
|
CN102940652B
(zh)
|
2008-05-28 |
2015-03-25 |
青岛东海药业有限公司 |
两形真杆菌制剂及其应用
|
US20110113863A1
(en)
|
2008-07-15 |
2011-05-19 |
Metanomics Health Gmbh |
Means and methods diagnosing gastric bypass and conditions related thereto
|
WO2010024251A1
(ja)
|
2008-08-26 |
2010-03-04 |
オリンパス株式会社 |
糞便試料の調製方法、糞便試料調製用溶液、及び採便用キット
|
WO2010030997A1
(en)
|
2008-09-12 |
2010-03-18 |
The Washington University |
Regulating intestinal microbiota dependent signaling as a means to modulate body fat and/or weight loss
|
EP2337569A4
(en)
|
2008-09-25 |
2013-04-03 |
Univ New York |
COMPOSITIONS AND METHODS FOR CHARACTERIZING AND RESTORING THE GASTROINTESTINAL, SKIN AND NASAL MICROBIOTA
|
CA2779413A1
(en)
|
2008-11-03 |
2010-06-03 |
Tufts University |
Methods and compositions for inhibiting clostridium difficile spore germination and outgrowth
|
GB0821913D0
(en)
|
2008-12-02 |
2009-01-07 |
Price & Co |
Antibacterial compounds
|
IT1393931B1
(it)
|
2009-02-25 |
2012-05-17 |
Neuroscienze Pharmaness S C A R L |
Composizione di spore di batteri non patogeni
|
US20120128633A1
(en)
|
2009-04-30 |
2012-05-24 |
Campagnie Gervaise Donone |
Use of collinsella aerofaciens for reducing bloating
|
BRPI1009920A2
(pt)
|
2009-05-01 |
2016-03-15 |
Micropharma Ltd |
composições bacterianas para profilaxina e tratamento de doença degenerativa.
|
US9050276B2
(en)
|
2009-06-16 |
2015-06-09 |
The Trustees Of Columbia University In The City Of New York |
Autism-associated biomarkers and uses thereof
|
US20120264637A1
(en)
|
2009-06-26 |
2012-10-18 |
The Regents Of The University Of California |
Methods and systems for phylogenetic analysis
|
WO2010151842A2
(en)
|
2009-06-26 |
2010-12-29 |
The Regents Of The University Of California |
Methods and systems for phylogenetic analysis
|
WO2011005756A1
(en)
|
2009-07-06 |
2011-01-13 |
Puretech Ventures, Llc |
Delivery of agents targeted to microbiota niches
|
PT2467031E
(pt)
|
2009-08-18 |
2014-10-30 |
Nestec Sa |
Composição nutricional compreendendo estirpes lactococcus e redução de sintomas de alergia, especialmente em bebés e crianças
|
WO2011022542A2
(en)
|
2009-08-19 |
2011-02-24 |
Puretech Ventures, Llc |
Administration of factors normally present in a microbial niche to improve health
|
US20120149584A1
(en)
|
2009-08-21 |
2012-06-14 |
Bernat Olle |
Methods of diagnosing and treating microbiome-associated disease using interaction network parameters
|
GB0916335D0
(en)
|
2009-09-17 |
2009-10-28 |
Martin W J |
Medicaments
|
CN102711819A
(zh)
|
2009-09-23 |
2012-10-03 |
托马斯·朱利叶斯·波洛迪 |
肠道感染疗法
|
US20120238468A1
(en)
|
2009-10-05 |
2012-09-20 |
Aak Patent B.V. |
Methods for diagnosing irritable bowel syndrome
|
US20110081320A1
(en)
|
2009-10-06 |
2011-04-07 |
Nubiome, Inc. |
Treatment/Cure of Autoimmune Disease
|
WO2011046616A2
(en)
|
2009-10-15 |
2011-04-21 |
New York University |
Methods for modulating bacterial infection
|
MX336032B
(es)
|
2009-11-12 |
2016-01-07 |
Nestec Sa |
Composicion nutricional para promover el balance y salud de la microbiota intestinal.
|
WO2011082218A1
(en)
|
2009-12-31 |
2011-07-07 |
Ira Milton Trachtman |
Compositions and method for treatment and prophylaxis of inflammatory bowel disease
|
US9492487B2
(en)
|
2010-02-01 |
2016-11-15 |
Matthew Ryan Garner |
Microbial product containing multiple microorganisms
|
EP4032586A1
(en)
|
2010-02-01 |
2022-07-27 |
Rebiotix, Inc. |
Bacteriotherapy for clostridium difficile colitis
|
US20130230498A1
(en)
|
2010-02-16 |
2013-09-05 |
Arizona Board Of Regents For And On Behalf Of Arizona State University |
Reducing short-chain fatty acids and energy uptake in obese humans by managing their intestinal microbial communities
|
NZ602473A
(en)
|
2010-03-01 |
2015-01-30 |
Agronomique Inst Nat Rech |
Method of diagnostic of obesity
|
JP2013520972A
(ja)
|
2010-03-01 |
2013-06-10 |
アンスティテュ ナシオナル ドゥ ラ ルシェルシュ アグロノミック |
炎症性腸疾患の診断方法
|
IT1398553B1
(it)
|
2010-03-08 |
2013-03-01 |
Probiotical Spa |
Composizione comprendente batteri probiotici per il trattamento di patologie associate con le alterazioni del sistema immunitario.
|
WO2011113801A1
(en)
|
2010-03-16 |
2011-09-22 |
Universiteit Gent |
Use of clostridium perfringens strain 23 to protect against necrotic enteritis
|
US8951512B2
(en)
|
2010-05-04 |
2015-02-10 |
New York University |
Methods for treating bone disorders by characterizing and restoring mammalian bacterial microbiota
|
WO2011151941A1
(ja)
|
2010-06-04 |
2011-12-08 |
国立大学法人東京大学 |
制御性t細胞の増殖または集積を誘導する作用を有する組成物
|
JP5940064B2
(ja)
|
2010-07-06 |
2016-06-29 |
ノバルティス アーゲー |
低用量のrnaを用いた大型哺乳動物の免疫化
|
WO2012009712A2
(en)
|
2010-07-16 |
2012-01-19 |
The Board Of Trustees Of The University Of Arkansas |
Methods and compositions including spore-forming bacteria for increasing the health of animals
|
FI20105825A
(fi)
|
2010-07-26 |
2012-01-27 |
Suomen Punainen Risti Veripalvelu |
Veriryhmästatuksen käyttö III
|
EP3311825A1
(en)
|
2010-08-04 |
2018-04-25 |
Thomas Julius Borody |
Compositions for fecal floral transplantation and methods for making and using them
|
WO2012024638A2
(en)
|
2010-08-20 |
2012-02-23 |
New York University |
Compositions and methods for treating obesity and related disorders by characterizing and restoring mammalian bacterial microbiota
|
CA2811056A1
(en)
|
2010-09-10 |
2012-03-15 |
Viropharma Incorporated |
Environmental clostridial bacteriotherapy and related formulations and methods of manufacture and use
|
KR20140033309A
(ko)
|
2010-10-04 |
2014-03-18 |
브리티쉬 콜롬비아 캔써 에이전시 브랜치 |
위장 암을 진단하기 위해 위장의 샘플에서의 푸소박테리움의 검출
|
US8802099B2
(en)
|
2010-11-10 |
2014-08-12 |
National Jewish Health |
Methods to treat allergic conditions
|
US20120064592A1
(en)
|
2011-01-26 |
2012-03-15 |
Qteros, Inc. |
Biocatalysts synthesizing deregulated cellulases
|
AP2013007097A0
(en)
|
2011-02-09 |
2013-09-30 |
Lavivo Ab |
Synbiotic compositions for restoration and reconstitution of gut microbiota
|
WO2012116289A2
(en)
|
2011-02-25 |
2012-08-30 |
Tricorder Diagnostics, Llc |
Microbial signatures as indicators of radiation exposure
|
WO2012122522A2
(en)
|
2011-03-09 |
2012-09-13 |
Washington University |
Cultured collection of gut microbial community
|
WO2012122478A1
(en)
|
2011-03-09 |
2012-09-13 |
Regents Of The University Of Minnesota |
Compositions and methods for transplantation of colon microbiota
|
WO2012142605A1
(en)
|
2011-04-15 |
2012-10-18 |
Samaritan Health Services |
Rapid recolonization deployment agent
|
US20120276056A1
(en)
|
2011-04-26 |
2012-11-01 |
Wieslaw Janusz Bochenek |
Method for Use of Biologic Agents Including Live or Dormant Forms of Bacteria and other organisms in Treating Infections, Inflammation and Other Diseases of Distal Small Intestine and Large Intestine
|
US20140179726A1
(en)
|
2011-05-19 |
2014-06-26 |
Virginia Commonwealth University |
Gut microflora as biomarkers for the prognosis of cirrhosis and brain dysfunction
|
US9579353B2
(en)
|
2011-06-10 |
2017-02-28 |
Prothera, Inc. |
Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes
|
WO2013008102A2
(en)
|
2011-07-14 |
2013-01-17 |
R.E.D. Laboratories N.V../ S.A. |
Methods and compositions for evaluating and/or treating chronic immune diseases
|
US20130022575A1
(en)
|
2011-07-19 |
2013-01-24 |
Microbial Rx |
Systems and methods of replacing intestinal flora
|
US20140348811A1
(en)
|
2011-07-27 |
2014-11-27 |
Max International, Llc |
Compositions comprising sugar-cysteine products
|
WO2013019896A1
(en)
|
2011-08-01 |
2013-02-07 |
Symbiotix Biotherapies, Inc. |
Platform for identifying and/or characterizing immunomodulatory agents
|
EP2753187B1
(en)
|
2011-08-30 |
2018-10-24 |
Caelus Pharmaceuticals B.V. |
Method for preventing and/or treating insulin resistance
|
EP2756071B1
(en)
|
2011-09-14 |
2017-12-20 |
University Of Guelph |
Media supplements and methods to culture human gastrointestinal anaerobic microorganisms
|
US20130121968A1
(en)
|
2011-10-03 |
2013-05-16 |
Atossa Genetics, Inc. |
Methods of combining metagenome and the metatranscriptome in multiplex profiles
|
US20130115232A1
(en)
|
2011-10-03 |
2013-05-09 |
Fred Hutchinson Cancer Research Center |
Methods for detecting graft-versus-host disease
|
GB201117313D0
(en)
|
2011-10-07 |
2011-11-16 |
Gt Biolog Ltd |
Bacterium for use in medicine
|
KR20140082964A
(ko)
|
2011-10-11 |
2014-07-03 |
아힘 바이오테라퓨틱스 에이비 |
혐기성 조건으로 배양된 인간 장내 미생물을 포함하는 조성물
|
CA2892588A1
(en)
|
2011-12-01 |
2013-06-06 |
School Corporation, Azabu Veterinary Medicine Educational Institution |
Human-derived bacteria that induce proliferation or accumulation of regulatory t cells
|
GB201201766D0
(en)
|
2012-02-01 |
2012-03-14 |
Imp Innovations Ltd |
Method
|
WO2013166031A1
(en)
|
2012-04-30 |
2013-11-07 |
The Washington University |
Method of isolating and characterizing microorganisms that are targets of host immune responses
|
DK2850202T3
(da)
|
2012-05-18 |
2020-05-18 |
Genome Res Ltd |
Fremgangsmåder og grupper
|
JP6257600B2
(ja)
|
2012-05-25 |
2018-01-10 |
スローン ケタリング インスティテュート フォア キャンサー リサーチ |
Gi症候群及び移植片対宿主病の治療方法
|
WO2013176774A1
(en)
|
2012-05-25 |
2013-11-28 |
Arizona Board Of Regents |
Microbiome markers and therapies for autism spectrum disorders
|
EP2684469A1
(en)
|
2012-07-13 |
2014-01-15 |
Nederlandse Organisatie voor toegepast -natuurwetenschappelijk onderzoek TNO |
Methods for strengthening and assessment of the natural defence of the colon against C. difficile overgrowth
|
BR112015011933A8
(pt)
|
2012-11-23 |
2022-09-20 |
Seres Therapeutics Inc |
Composições bacterianas sinérgicas e métodos de produção e uso das mesmas
|
US8906668B2
(en)
|
2012-11-23 |
2014-12-09 |
Seres Health, Inc. |
Synergistic bacterial compositions and methods of production and use thereof
|
US11185562B2
(en)
|
2013-02-04 |
2021-11-30 |
Seres Therapeutics, Inc. |
Compositions and methods for inhibition of pathogenic bacterial growth
|
EP3904502A3
(en)
|
2013-02-04 |
2022-02-23 |
Seres Therapeutics, Inc. |
Compositions and methods
|
EP2971148A4
(en)
|
2013-03-14 |
2016-08-17 |
Seres Therapeutics Inc |
METHODS OF DETECTING PATHOGENS AND ENRICHING FROM MATERIALS AND COMPOSITIONS
|
JP2016519664A
(ja)
*
|
2013-03-15 |
2016-07-07 |
セレス セラピューティクス インコーポレイテッド |
ネットワークを基にした微生物組成物及び方法
|
US9962415B2
(en)
|
2013-05-03 |
2018-05-08 |
Nestec S.A. |
Lachnospiraceae in the gut microbiota and association with body weight
|
ES2705351T3
(es)
*
|
2013-08-05 |
2019-03-22 |
Daiichi Sankyo Co Ltd |
Método para la investigación del tipo de daño hepático
|
WO2015018308A1
(en)
|
2013-08-06 |
2015-02-12 |
BGI Shenzhen Co.,Limited |
Biomarkers for colorectal cancer
|
WO2015077794A1
(en)
|
2013-11-25 |
2015-05-28 |
Seres Health, Inc. |
Synergistic bacterial compositions and methods of production and use thereof
|
EP3082431A4
(en)
|
2013-12-16 |
2017-11-15 |
Seres Therapeutics, Inc. |
Bacterial compositions and methods of use thereof for treatment of immune system disorders
|
MA41020A
(fr)
|
2014-11-25 |
2017-10-03 |
Evelo Biosciences Inc |
Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
|
BR112018010430A2
(pt)
|
2015-11-24 |
2018-11-27 |
Seres Therapeutics Inc |
composições bacterianas projetadas
|
WO2017102816A1
(en)
*
|
2015-12-14 |
2017-06-22 |
Metabogen Ab |
Treatment of intrahepatic cholestasis and related liver diseases
|
AU2017234120A1
(en)
|
2016-03-14 |
2018-09-20 |
Holobiome, Inc. |
Modulation of the gut microbiome to treat mental disorders or diseases of the central nervous system
|
WO2019036510A1
(en)
|
2017-08-14 |
2019-02-21 |
Seres Therapeutics, Inc. |
COMPOSITIONS AND METHODS FOR TREATING CHOLESTATIC DISEASE
|
EP3691664A4
(en)
|
2017-10-03 |
2021-08-04 |
Seres Therapeutics, Inc. |
MANIPULATION OF TRYPTAMINE METABOLISM
|
CA3080586A1
(en)
|
2017-10-30 |
2019-05-09 |
Seres Therapeutics, Inc. |
Compositions and methods for treating antibiotic resistance
|
AU2019245430A1
(en)
|
2018-03-29 |
2020-10-22 |
Seres Therapeutics, Inc. |
Compositions and methods for treating inflammatory bowel diseases
|
CA3101184A1
(en)
|
2018-05-24 |
2019-11-28 |
Seres Therapeutics, Inc. |
Designed bacterial compositions and uses thereof
|